Fidelity Investments’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-100
Closed -$231 5888
2024
Q3
$231 Sell
100
-640
-86% -$1.44K ﹤0.01% 5028
2024
Q2
$1.79K Buy
740
+640
+640% +$1.63K ﹤0.01% 4742
2024
Q1
$293 Sell
100
-525
-84% -$1.66K ﹤0.01% 4890
2023
Q4
$1.85K Buy
625
+525
+525% +$1.4K ﹤0.01% 4661
2023
Q3
$397 Hold
100
﹤0.01% 4736
2023
Q2
$456 Hold
100
﹤0.01% 4819
2023
Q1
$525 Hold
100
﹤0.01% 4788
2022
Q4
$494 Hold
100
﹤0.01% 4749
2022
Q3
$1K Hold
100
﹤0.01% 4765
2022
Q2
$1K Hold
100
﹤0.01% 4828
2022
Q1
$1K Hold
100
﹤0.01% 4867
2021
Q4
$1K Hold
100
﹤0.01% 4228
2021
Q3
$1K Hold
100
﹤0.01% 4221
2021
Q2
$1K Hold
100
﹤0.01% 4128
2021
Q1
$1K Hold
100
﹤0.01% 3901
2020
Q4
$1K Hold
100
﹤0.01% 3749
2020
Q3
$0 Hold
100
﹤0.01% 4061
2020
Q2
$1K Hold
100
﹤0.01% 3512
2020
Q1
$1K Hold
100
﹤0.01% 3547
2019
Q4
$1K Hold
100
﹤0.01% 3702
2019
Q3
$1K Sell
100
-48
-32% -$408 ﹤0.01% 3694
2019
Q2
$1K Hold
148
﹤0.01% 3659
2019
Q1
$2K Sell
148
-92
-38% -$1.58K ﹤0.01% 3453
2018
Q4
$4K Sell
240
-57
-19% -$982 ﹤0.01% 3247
2018
Q3
$6K Buy
+297
New +$5.91K ﹤0.01% 3235
2014
Q2
Sell
-113,057
Closed -$1.94M 2807
2014
Q1
$1.94M Buy
113,057
+37,027
+49% +$614K ﹤0.01% 2389
2013
Q4
$1.12M Sell
76,030
-20,201
-21% -$278K ﹤0.01% 2437
2013
Q3
$1.27M Sell
96,231
-72,725
-43% -$903K ﹤0.01% 2413
2013
Q2
$1.81M Buy
+168,956
New +$1.9M ﹤0.01% 2328

Other funds holding PMD

Fidelity Investments's PMD Position: Q4 2024 in Review

Fidelity Investments sold out of Psychemedics Corporation (PMD) in Q4 2024, closing a stake of 100 shares — an estimated $231 sold.

Fidelity Investments first reported a position in PMD in Q2 2013 and held it in 29 quarters. The position peaked at $1.94M in Q1 2014. 3 funds tracked by Wall St. Rank hold PMD as of Q4 2024.

  • Fidelity Investments reported no remaining Psychemedics Corporation position as of Q4 2024 after selling out during the quarter.
  • Fidelity Investments sold 100 Psychemedics Corporation shares in Q4 2024, an estimated $231.
  • Fidelity Investments first reported a position in Psychemedics Corporation in Q2 2013 and held it in 29 quarters.
  • Fidelity Investments's Psychemedics Corporation position peaked at $1.94M in Q1 2014.
  • 3 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2024.

Based on Fidelity Investments's 13F filing for Q4 2024, filed 13 Feb 2025.